Choice of initial antiepileptic drug for older veterans: Possible pharmacokinetic drug interactions with existing medications

Journal of the American Geriatrics Society

Volumn 58, Issue 3, 2010, Pages 465-471

  Pugh, Mary Jo V ^a,b   Vancott, Anne C ^c,d   Steinman, Michael A ^e,f   Mortensen, Eric M ^a,b   Amuan, Megan E ^c   Wang, Chen Pin ^a,b   Knoefel, Janice E ^f,g,h   Berlowitz, Dan R ^c,i  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^h UNIVERSITY OF NEW MEXICO   (United States)

ⁱ BOSTON UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Drug drug interaction; Epilepsy; Geriatrics

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; CARBAMAZEPINE; CARDIOVASCULAR AGENT; DILTIAZEM; DISOPYRAMIDE; FELODIPINE; FLUINDOSTATIN; LIPID; METOPROLOL; MEVINOLIN; MEXILETINE; NEFAZODONE; NIFEDIPINE; NIMODIPINE; NORTRIPTYLINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PROPRANOLOL; PSYCHOTROPIC AGENT; QUINIDINE; SIMVASTATIN; TICLOPIDINE; VALPROIC ACID; VERAPAMIL; WARFARIN;

AGED; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE MONITORING; CHRONIC DISEASE; COHORT ANALYSIS; DEMOGRAPHY; DRUG EXPOSURE; EMERGENCY CARE; EPILEPSY; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGY; OUTCOME ASSESSMENT; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; STROKE; VETERAN;

AGED; AGED, 80 AND OVER; ANTICONVULSANTS; COMORBIDITY; DRUG INTERACTIONS; DRUG MONITORING; EPILEPSY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; POLYPHARMACY; UNITED STATES; VETERANS;

EID: 77949362520     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02732.x     Document Type: Article

References (38)

1. Hauser WA. Seizure disorders: The changes with age. Epilepsia 1992;33: S6-S14.
2. Rowan AJ, Ramsay RE, Collins JF et al. New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-1873.
3. Leppik IE, Birnbaum A. Epilepsy in the elderly. Semin Neurol 2002;22: 309-320.
4. Willmore LJ. Antiepileptic drug therapy in the elderly. Pharmacol Ther 1998;78:9-16.
5. Rowan AJ. Seizure. Fundamentals of drug management of epilepsy in the older patient. Geriatrics 2002;57:33-37; quiz 38.
6. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003;2:473-481.
7. Patsalos PN, FroscherW, Pisani F et al. The importance of drug interactions in epilepsy therapy. Epilepsia 2002;43:365-385.
8. Mancia G. Prevention and treatment of stroke in patients with hypertension. Clin Ther 2004;26:631-648.
9. Bejot Y, Ben Salem D, Osseby GV et al. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006. Neurology 2009;72:346-353.
10. Delahoy PJ,Magliano DJ,Webb K et al. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis. Clin Ther 2009;31:236-244.
11. Gidal BE, French JA, Grossman P et al. Assessment of potential drug interactions in patients with epilepsy: Impact of age and sex. Neurology 2009;72:419-425.
12. Holden EW, Grossman E, Nguyen HTet al. Developing a computer algorithm to identify epilepsy cases in managed care organizations. Dis Manage 2005;8:1-14.
13. Pugh MJ, Van Cott AC, Cramer JA et al. Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004. Neurology 2008;70:2171-2178.
14. Micromedic. Drug-Reax* system. In: Gelman CR, Rumack BH, editors. Micromedex Intranet Knowledge Bases. Denver, CO: Micromedex, Inc., 2003.
15. Elixhauser A, Steiner C, Harris DR et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
16. Selim AJ, Berlowitz DR, Ren XS et al. The comorbidity index. In: Davies M, editor. Measuring and Managing Health Care Quality, Vol. 4. New York: Aspen Publishers, 2002, pp 91-94.
17. Krishnan LL, Petersen NJ, Snow AL et al. Prevalence of dementia among Veterans Affairs medical care system users. Dement Geriatr Cogn Disord 2005;20:245-253.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613-619.
19. So EL, Annegers JF, Hauser WA et al. Population-based study of seizure disorders after cerebral infarction. Neurology 1996;46:350-355.
20. Dhanuka AK, Misra UK, Kalita J. Seizures after stroke: A prospective clinical study. Neurol India 2001;49:33-36.
21. Amatniek JC, Hauser WA, Delcastillo-Castaneda C et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006;47:867-872.
22. Lozsadi DA, Larner AJ. Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease. Dement Geriatr Cogn Disord 2006;22:121-124.
23. Pugh MJ, Hanlon JT, Zeber JE et al. Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manage Care Pharm 2006;12:537-545.
24. Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). The State of Aging and Health in America 2007. Whitehouse Station, NJ: The Merck Company Foundation, 2007.
25. Flockhart DA, Tanus-Santos JE. Implications of cytochrome P450 interactions when prescribing medication for hypertension. Arch Intern Med 2002;162:405-412.
26. Michelucci R, Cipolla G, Passarelli D et al. Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy. Epilepsia 1996;37:1107-1110.
27. Fischer TL, Pieper JA, Graff DW et al. Evaluation of potential losartanphenytoin drug interactions in healthy volunteers. Clin Pharmacol Ther 2002;72:238-246.
28. Bahls FH, Ozuna J, Ritchie DE. Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin. Neurology 1991;41:740-742.
29. Ucar M, Neuvonen M, Luurila H et al. Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid. Eur J Clin Pharmacol 2004;59:879-882.
30. Piecoro LT, Browning SR, Prince TS et al. A database analysis of potentially inappropriate drug use in an elderly medicaid population. Pharmacotherapy 2000;20:221-228.
31. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004;164:305-312.
32. PughMJ, Fincke BG, Bierman A et al. Potentially inappropriate prescribing in elderly veterans: Are we using the wrong drug, wrong dose, or wrong duration? J Am Geriatr Soc 2005;53:1282-1289.
33. Willmore LJ. Choice and use of newer anticonvulsant drugs in older patients. Drugs Aging 2000;17:441-452.
34. Bierman AS, Pugh MJ, Dhalla I et al. Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother 2007;5:147-161.
35. Kaboli PJ, McClimon BJ, Hoth AB et al. Assessing the accuracy of computerized medication histories. Am J Manage Care 2004;10:872-877.
36. Hope OA, Zeber JE, Kressin NR et al. New-onset geriatric epilepsy care: Race, setting of diagnosis, and choice of antiepileptic drug. Epilepsia 2009;50:1085-1093.
37. Cowper PA,Weinberger M, Hanlon JTet al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998;18:327-332.
38. Terrell KM, Perkins AJ, Dexter PR et al. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: A randomized, controlled trial. J Am Geriatr Soc 2009;57:1388-1394.